Walter H
4. Medizinische Klinik des Klinikums Nürnberg, Universität Erlangen-Nürnberg.
Z Gesamte Inn Med. 1993 Mar;48(3):135-9.
New findings concerning the dynamic of insulin secretion, insulin action and pharmacokinetics of insulin preparations have caused a complete change of insulin therapy in diabetes mellitus (basis-bolus-concept). At the same time, the discrepancy between insulin substitution and physiologic conditions becomes evident. Even the use of human insulin or the development of insulin-pens and -pumps does not influence that fact. From the beginning of insulin therapy till now the subcutaneous injection of insulin is the safest and easiest way of application. By means of modified insulins (bioengineering) the physico-chemical process of insulin resorption could be elucidated in the last 4 years. In clinical experiments the intraperitoneal and nasal insulin administration is tested extensively. In the field of the intensified insulin therapy including near normoglycemic therapeutic goals the awareness of hypoglycemia is of particular importance.
关于胰岛素分泌动态、胰岛素作用及胰岛素制剂药代动力学的新发现,已使糖尿病胰岛素治疗发生了彻底改变(基础-餐时胰岛素治疗方案)。与此同时,胰岛素替代治疗与生理状况之间的差异变得明显。即使使用人胰岛素或胰岛素笔及胰岛素泵的发展也并未改变这一事实。从胰岛素治疗开始至今,皮下注射胰岛素仍是最安全、最简单的给药方式。在过去4年里,借助改良胰岛素(生物工程技术),胰岛素吸收的物理化学过程得以阐明。在临床试验中,腹腔内和鼻内胰岛素给药正在被广泛测试。在包括接近正常血糖治疗目标的强化胰岛素治疗领域,低血糖意识尤为重要。